| Jan 10, 12 | Marks & Spencer lifted by food sales, while Debenhams beats forecasts | | No data |
| Jan 9, 12 | FTSE falters again, as Glaxo reveals mixed drug trial results and AstraZeneca sends out wrong data | | No data |
| Jan 9, 12 | GlaxoSmithKline drops on drug trial results, while AstraZeneca gives City wrong data | | No data |
| Jan 6, 12 | ITV gains but BSkyB loses after analyst report, while FTSE ends up on week | | No data |
| Dec 31, 11 | New Year honours include an award for tycoon jailed over stock market scandal | | No data |
| Dec 20, 11 | FTSE 100 gains ground, while Burberry moves higher on French venture move | | No data |
| Dec 20, 11 | AstraZeneca drops 2.5% after drug failures and write-off, but FTSE struggles for direction | | No data |
| Dec 12, 11 | Imperial Tobacco in demand as FTSE 100 slips back on eurozone woes | | No data |
| Dec 9, 11 | Market reaction muted as UK exits European bailout talks | | No data |
| Dec 8, 11 | FTSE falls 1% as nervousness grows ahead of EU summit | | No data |
| Dec 8, 11 | Cairn aims to return $3.5bn to shareholders, while FTSE awaits banks decisions and summit | | No data |
| Dec 6, 11 | FTSE wavers ahead of EU summit but retailers routed on fears of poor Christmas | | No data |
| Dec 6, 11 | Wolseley builds up 2% rise despite US asbestos problem, as FTSE drifts lower | | No data |
| Nov 30, 11 | Miners under pressure on downturn worries, as FTSE 100 falls back again | | No data |
| Nov 24, 11 | Sir James Dyson funds £1.4m professorship at Cambridge University | | No data |
| Nov 22, 11 | How boardroom excess is eroding trust in business | | No data |
| Nov 21, 11 | Pharmaceuticals struggle to find next blockbuster drugs as R&D costs soar | | No data |
| Nov 18, 11 | Capita slumps more than 4% after cautious outlook, as FTSE falters again | | No data |
| Nov 3, 11 | GlaxoSmithKline pays £1.9bn to settle US legal inquiries | | No data |
| Nov 2, 11 | FTSE rebounds after two days of losses, but Logica drops 7% after trading update | | No data |
| Oct 31, 11 | FTSE falls 2.7% on renewed Eurozone worries, but still records 13th best month | | No data |
| Oct 31, 11 | Mining groups lead FTSE 100 lower as Eurozone euphoria wears off | | No data |
| Oct 27, 11 | AstraZeneca sees pressures from price cuts and generic drug competition | | No data |
| Oct 26, 11 | Glittering gold lifts Fresnillo out of a flat FTSE | | No data |
| Oct 26, 11 | GSK shares buoyed by return to growth | | No data |
| Oct 19, 11 | Malaria vaccine: many in scientific community thought it was impossible | | No data |
| Oct 18, 11 | Malaria vaccine set to save millions of lives, but who will fund it? | | No data |
| Oct 18, 11 | Malaria vaccine could save millions of children's lives | | No data |
| Jul 27, 11 | Glaxo may have the cure for its own ills | | No data |
| Jul 26, 11 | GSK gives UK economy boost with job and tax pledge | | No data |